SPECIAL REPORT: Update on the Johnson & Johnson COVID-19 Vaccine and Blood Clot Risk

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

NHL Pacific Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 8PM EDT 4 min · 25 Sep 2026 · NPR News Now

Fletch, Vaughan & Hayley's Lil Bitta Pod - 25th September 2026 7 min · 25 Sep 2026 · ZM's Fletch, Vaughan & Hayley

Send Me To Sleep | Orchards 48 min · 25 Sep 2026 · Send Me To Sleep

Fletch, Vaughan & Hayley's Big Pod - 25th September 2026 1h 27m · 25 Sep 2026 · ZM's Fletch, Vaughan & Hayley

8PM ET 09/24/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded22 Apr 2021

Publisherneurology.libsyn.com ↗

Handlerec:5447789

Show notes

Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related